Daily Trades
- Dylan Jovine
I recommend selling half your shares in Krystal Biotech (SYM: KRYS) here at $170.09, a 120% gain from our recommended price of $76.94.
- Dylan Jovine
Lots of folks wrote in yesterday to ask about Krystal Biotech (SYM: KRYS).
- Dylan Jovine
Trade Alert: Lock in some profits on Krystal Biotech (SYM: KRYS)....
- Dylan Jovine
Let's start by closing out one of our older positions for a small profit.
- Dylan Jovine
Lot's of folks writing in today, so I figured I'd send this note to the whole group instead of to one member at a time.
- Dylan Jovine
Krystal Biotech (SYM: KRYS) hit an all-time high today of $95 on winning FDA approval of Vyjuvek, a topical gene therapy for dystrophic epidermolysis bullosa (DEB).
- Dylan Jovine
Investors may want to keep an eye on the biotech boom. For one, the sector is still one of the safest, most recession-proof investments around.
deal of the month
Categories
New Housing Report Coming This Week! 👀 @MarketBeatMedia
Dylan Jovine | JP Morgan's CEO Says - "Conditions Are Treacherous and Getting Worse"
Commodity Price Drops: A Recession Warning? @MarketBeatMedia
Recent posts
Tags
Connect with Us
- Dylan Jovine
I recommend selling half your shares in Krystal Biotech (SYM: KRYS) here at $170.09, a 120% gain from our recommended price of $76.94.
- Dylan Jovine
Lots of folks wrote in yesterday to ask about Krystal Biotech (SYM: KRYS).
- Dylan Jovine
Trade Alert: Lock in some profits on Krystal Biotech (SYM: KRYS)....
- Dylan Jovine
Let's start by closing out one of our older positions for a small profit.
- Dylan Jovine
Lot's of folks writing in today, so I figured I'd send this note to the whole group instead of to one member at a time.
- Dylan Jovine
Krystal Biotech (SYM: KRYS) hit an all-time high today of $95 on winning FDA approval of Vyjuvek, a topical gene therapy for dystrophic epidermolysis bullosa (DEB).
- Dylan Jovine
Investors may want to keep an eye on the biotech boom. For one, the sector is still one of the safest, most recession-proof investments around.
Get FREE Daily Stock Tips
Join and receive market insider stock picks, trade alerts and unique investing insights
By clicking the "Subscribe" button you are accepting our Terms of Use and Privacy Policy.
